Should pseudomonas aeruginosa be the main target in bronchiectasis?

Fatma Isil Uzel (Istanbul, Turkey), Fatma Isil Uzel, Sedat Altin, Seyma Özden, Derya Hirçin Çenger, Esin Tuncay

Source: International Congress 2016 – Monitoring comorbidities
Session: Monitoring comorbidities
Session type: Thematic Poster
Number: 4165
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Fatma Isil Uzel (Istanbul, Turkey), Fatma Isil Uzel, Sedat Altin, Seyma Özden, Derya Hirçin Çenger, Esin Tuncay. Should pseudomonas aeruginosa be the main target in bronchiectasis?. Eur Respir J 2016; 48: Suppl. 60, 4165

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A comprehensive analysis of the impact of pseudomonas aeruginosa colonisation in adult bronchiectasis
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015


Pseudomonas aeruginosa isolates in bronchiectasis: Wath particulaties and risk factors?
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016


Aminoglycoside use for pseudomonas aeruginosa in bronchiectasis
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Patients with no cystic fibrosis bronchiectasis colonized by pseudomonas aeruginosa: Role of inhaled colistin
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014


Pseudomonas aeruginosa colonisation in patients without bronchiectasis
Source: International Congress 2014 – Clinical management of lung diseases: from bronchi to pleura
Year: 2014

Inhaled colistin in patients with non - cystic fibrosis bronchiectasis and chronic pseudomonas aeruginosa bronquial infection
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016


Atorvastatin as novel treatment in bronchiectasis patients colonized with pseudomonas aeruginosa
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016


Genotypic studies of pseudomonas aeruginosa isolates from adult non-cystic fibrosis bronchiectasis patients
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015

Role of stenotrophomonas maltophilia infection in CF pulmonary exacerbations
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013


Pseudomonas aeruginosa pneumonia in the community
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014


Bacterial colonization in patients with bronchiectasis
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014


Pseudomonas aeruginosa from CF airways uses various strategies to outcompete staphylococcus aureus
Source: International Congress 2016 – Cystic fibrosis: inflammation, microbiology, management and monitoring
Year: 2016


Pulmonary infections with pseudomonas aeruginosa
Source: Eur Respir J 2004; 24: Suppl. 48, 642s
Year: 2004

Azithromycin therapy and pseudomonas aeruginosa isolation in a non-cystic fibrosis bronchiectasis cohort
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015


Nicotinamide and bacterial killing in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014


Nontuberculous mycobacteria lung infection in bronchiectasis: Prevalence and clinical characteristics
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014

COPD and pseudomonas aeruginosa, an association
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014


Pseudomonas aeruginosa infections
Source: Respipedia Article
Year: 2018

Microbial aetiology and outcomes of CAP in bronchiectatic patients
Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients
Year: 2013


Exacerbations and pneumonia in bronchiectasis: Clinical and microbiological characterization
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015